Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Eva Rubio-Azpeitia"'
Autor:
Juan-Manuel Sancho, Ana Marín-Niebla, Silvia Fernández, Francisco-Javier Capote, Carolina Cañigral, Carlos Grande, Eva Donato, Izaskun Zeberio, Jose-Manuel Puerta, Alfredo Rivas, Elena Pérez-Ceballos, Ana Vale, Alejandro Martín García-Sancho, Antonio Salar, Eva González-Barca, Anabel Teruel, Carmen Pastoriza, Diego Conde-Royo, Joaquín Sánchez-García, Cristina Barrenetxea, Reyes Arranz, José-Ángel Hernández-Rivas, María-José Ramírez, Aroa Jiménez, Eva Rubio-Azpeitia
Publikováno v:
INTERNATIONAL JOURNAL OF HEMATOLOGY
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
International Journal of Hematology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
r-FISABIO. Repositorio Institucional de Producción Científica
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
International Journal of Hematology
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
r-FISABIO. Repositorio Institucional de Producción Científica
This retrospective study evaluated 66 patients diagnosed with relapsed and/or refractory mantle cell lymphoma (R/R MCL) treated with ibrutinib in Spain in routine clinical practice. At diagnosis, patients had a median age of 64.5 years, 63.6% present
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33fbc67fbf5b2c7eef5c8a06b0493fb6
https://doi.org/10.1007/s12185-022-03367-z
https://doi.org/10.1007/s12185-022-03367-z
Autor:
Eva Rubio‐Azpeitia, Ana Maria Pérez‐Corral, Nieves Dorado‐Herrero, Silvia Monsalvo, Gonzalo Pérez‐Balsera, Maria Eugenia Fernández‐Santos, Mi Kwon, Gillen Oarbeascoa, Mariana Bastos‐Oreiro, Carmen Falero, Cristina Pascual Izquierdo, Cristina Muñoz‐Martínez, Antonio Pérez‐Martínez, José Luis Diez‐Martin, Javier Anguita
Publikováno v:
Transfusion. 62:374-385
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f0e107f029822993a7b28796c0fa8519
https://doi.org/10.1111/trf.16790
https://doi.org/10.1111/trf.16790
Autor:
Eva, Rubio-Azpeitia, Ana Maria, Pérez-Corral, Nieves, Dorado-Herrero, Silvia, Monsalvo, Gonzalo, Pérez-Balsera, Maria Eugenia, Fernández-Santos, Mi, Kwon, Gillen, Oarbeascoa, Mariana, Bastos-Oreiro, Carmen, Falero, Cristina, Pascual Izquierdo, Cristina, Muñoz-Martínez, Antonio, Pérez-Martínez, José Luis, Diez-Martin, Javier, Anguita
Publikováno v:
TransfusionREFERENCES. 62(2)
Allogeneic stem cell transplantation is the treatment of choice for acute myeloid leukemia (AML) patients. Unmanipulated haploidentical transplantation (Haplo-HSCT) is commonly used for those AML patients who need a timely transplant and do not have
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1e8149aa021f572eb1057c9601bda20a
https://pubmed.ncbi.nlm.nih.gov/35023148
https://pubmed.ncbi.nlm.nih.gov/35023148
Autor:
Patricia Sánchez, Clara I. Rodríguez, Eva Rubio-Azpeitia, Isabel Andia, Arantza Infante, Raúl Alberdi
Publikováno v:
Tissue Engineering and Regenerative Medicine. 14:567-577
We aim to examine the influence of platelet rich plasma (PRP) and spatial cues in cartilage/bone matrix forming proteins, and to evaluate the mitotic and chemotactic potential of PRP on human mesenchymal stem cells (hMSCs). Directed cell migration to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f69a9b1082a2071e5a924436b1c47efa
https://doi.org/10.1007/s13770-017-0062-1
https://doi.org/10.1007/s13770-017-0062-1
Autor:
Andima Basterretxea, Eva Rubio-Azpeitia, Elena Perez-Zabala, Ainara Larrazabal, Isabel Andia, Karmele Perez-del-Pecho
Publikováno v:
Journal of Tissue Viability. 25:157-163
Objective To show an approach to profit of the main components of platelet rich plasma (PRP), i.e. the signaling proteins, and the fibrin scaffold and discuss the intervention within TIME (Tissue, Inflammation/Infection, Moisture, Edges) framework. M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9373441578bbf15f36347a6663799dab
https://doi.org/10.1016/j.jtv.2016.03.003
https://doi.org/10.1016/j.jtv.2016.03.003
Autor:
Teodoro Palomares, Jose-Ramon Sarasua, Francisco Javier Martin, Eva Rubio-Azpeitia, Ana Alonso-Varona, Aitor Larrañaga, Pablo Aldazabal
Publikováno v:
Journal of Biomedical Materials Research Part A. 103:3815-3824
Incorporation of bioactive glass (BG) particles to synthetic polymer scaffolds is a promising strategy to improve the bioactivity of bioinert materials and to stimulate specific cell responses. In this study, the influence of incorporating BG particl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c6837d2084a73aea0de8fc3c2a544bac
https://doi.org/10.1002/jbm.a.35525
https://doi.org/10.1002/jbm.a.35525
Publikováno v:
Cells Tissues Organs. 200:394-404
Since the experimental conditions of cell cultures may bias results, it is critical to use suitable models. This is also true in the context of tendon cell biology and the study of platelet-rich plasma (PRP) therapies and PRP-augmented cell-based the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e34d728a41aff05841f5079772b58929
https://doi.org/10.1159/000441053
https://doi.org/10.1159/000441053
Publikováno v:
The American journal of sports medicine. 44(8)
Background: Tendinopathies are attributed to failure of the healing process and inadequate tissue remodeling. Plasma injections can trigger regenerative responses by modifying the molecular microenvironment. Purpose: To examine the differences in the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83827e57040f2fa0cb355510f93b46b7
https://pubmed.ncbi.nlm.nih.gov/27161868
https://pubmed.ncbi.nlm.nih.gov/27161868
Publikováno v:
Platelet Rich Plasma in Musculoskeletal Practice ISBN: 9781447172703
Tendons are prone to chronic lesions, especially in the presence of risk factors such as overuse, trauma and metabolic disorders. Current therapies cannot meet the clinical demand for tendon conditions, and biological interventions such as Platelet R
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0674da376df7edc39621c3b7b8b3250c
https://doi.org/10.1007/978-1-4471-7271-0_10
https://doi.org/10.1007/978-1-4471-7271-0_10
Autor:
Eric T. Everett, Satz Mengensatzproduktion, Zhaoyu Yin, Toshihiko Iwanaga, Pello Sánchez, Jeremy K. Brown, Alessandro Filippo Pellegata, W. Colin Duncan, Eva Rubio-Azpeitia, Diego Delgado, Sandro Zonta, Ryosuke Nakamura, Lu Liu, Filippo Ballo, Gianpaolo Zerbini, Jian Li, E. Angeles Martinez-Mier, John S. Preisser, Werner Druck Medien Ag, Fumio Nakamura, Junko Nio-Kobayashi, M. Adelaide Asnaghi, Tommaso Dominioni, Chaitanya P. Puranik, Ying Zhang, Andrew W Horne, Silvia Maestroni, Sara Mantero, Isabel Andia, Shuang Lei, Shigeharu Fukunaga, Kathleen A. Ryan, Kaiqiang Zhang, Hazirah B. Z. Abidin
Publikováno v:
Cells Tissues Organs. 200
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6807e461883144d883be856830244f18
https://doi.org/10.1159/000442272
https://doi.org/10.1159/000442272